홈 › 유방암 › 미시간

미시간의 유방암 임상 시험

유방암 관련 연구 72개가 미시간 내 여러 지역에서 참여자를 모집하고 있습니다.

미시간의 도시

공식 연구 텍스트(영어)

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Cancer and Hematology Centers of Western Michigan, Grand Rapids

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05696626

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Henry Ford Hospital, Detroit

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05894239

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Profound Research LLC at Michigan Hematology and Oncology Consultants, Royal Oak

피험자 모집 중1상

18세 ~ 55세 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07310420

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

Cancer and Leukemia Center, Sterling Heights

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07541079

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Saint Joseph Mercy Hospital, Ann Arbor
University of Michigan Comprehensive Cancer Center, Ann Arbor
McLaren Cancer Institute-Bay City, Bay City
외 16개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03418961

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Research Facility, Detroit

피험자 모집 중1/2상

전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06590857

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Karmanos Cancer Institute, Detroit
Brigitte Harris Cancer Pavilion BHCP, Detroit
START Midwest, LLC, Grand Rapids

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06827236

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

START Midwest, Grand Rapids

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT04557449

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

University of Michigan Rogel Cancer Center, Ann Arbor

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07007559

The Vanguard Study: Testing a New Way to Screen for Cancer

Henry Ford Cancer Institute-Downriver, Brownstown
Henry Ford Health Center - Brownstown, Brownstown
Henry Ford Health Center - Chesterfield, Chesterfield
외 13개

피험자 모집 중건강한 지원자 환영

45세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06995898

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07029399

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

University of Michigan, Ann Arbor

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06324357

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

START Midwest, LLC, Grand Rapids

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07318805

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Karmanos Cancer Center - Wayne State University, Detroit
Cancer & Hematology Centers, Grand Rapids
Munson Medical Center Cowell Family Cancer Center, Traverse City

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07214532

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

University of Michigan, Ann Arbor
Profound Research LLC, Royal Oak

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06982521

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Henry Ford Health System, Detroit
Cancer & Hematology Centers of Western Michigan, Grand Rapids

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06790693

E-Mindfulness Approaches for Living After Breast Cancer

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
외 21개

피험자 모집 중3상

18세 ~ 50세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06748222

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
외 71개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Karmanos Cancer Institute, Detroit
START Midwest, Grand Rapids

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
외 19개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Barbara Ann Karmanos Cancer Institute, Detroit
BAMF Health Inc., Grand Rapids

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213791

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Barbara Ann Karmanos Cancer Institute, Detroit
BAMF Health Inc., Grand Rapids

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07114601

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
외 77개

피험자 모집 중3상

18세 ~ 60세 · 여성 · 2026. 11. 4. 업데이트됨 · NCT05879926

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Karmanos Cancer Center, Detroit
Profound Research LLC at Michigan Hematology and Oncology Consultants, Royal Oak

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07173751

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Henry Ford Hospital, Detroit

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07102381

A Study of MGC026 in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06242470

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Wayne State University - Barbara Ann Karmanos Cancer Institute, Detroit

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07287917

The Cancer of the Pancreas Screening-5 CAPS5)Study

University of Michigan, Ann Arbor

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT02000089

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

The Cancer & Hematology Centers, Big Rapids
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
The Cancer & Hematology Centers, Grand Rapids
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07062965

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor

피험자 모집 중3상

22세 이상 · 여성 · 2026. 10. 19. 업데이트됨 · NCT05379153

CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

University of Michigan Comprehensive Cancer Center, Ann Arbor

피험자 모집 중

전 연령 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06915168

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Karmanos Cancer Institiute, Detroit

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06293898

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Henry Ford Health ( Site 0002), Detroit

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06312176

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Henry Ford Hospital, Detroit

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT05386108

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Henry Ford Health System, Detroit

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06757634

A Study of PHST001 in Advanced Solid Tumors

University of Michigan Rogel Cancer Center, Ann Arbor
START Center for Cancer Research - Midwest, Grand Rapids

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06840886

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

START - Midwest, Grand Rapids

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06784193

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

McLaren Proton Therapy Center, Flint

피험자 모집 중2상

50세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT01766297

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Detroit

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.